NGF and neoplasm: Sensory nerves accelerate the progression of head and neck cancers.[23] Therapeutic strategies targeting nerve‐tumor crosstalk (e.g., via NGF inhibition) show promising anti‐tumor effects.[24, 25] Clinically, increased nerve density is associated with poor prognosis in various cancers.[26, 27, 28] Notably, while normal lymph nodes are densely innervated by sympathetic nerves that regulate immune function through β2‐adrenergic receptor signaling[29, 30, 31, 32], the potential involvement of peripheral nerves in EBV+ DLBCL remains completely unexplored.